← SynDRA
(3Z)-3-[[4-(dimethylamino)phenyl]methylidene]-1H-indol-2-one
SynDRA canonical compound SYN0201519 — structure-anchored drug synonym record
Clinical phase
Preclinical
Primary target(s)
KDR | PDGFRB
Mechanism of action
PDGFR tyrosine kinase receptor inhibitor | tyrosine kinase inhibitor | VEGFR inhibitor
Cross-references
PubChem CID:
6450842
ChEMBL:
CHEMBL328710
Synonyms
SU 4312
SU4312
NSC86429
cis-SU4312
(Z)-SU4312
(Z)-3-(4-(dimethylamino)benzylidene)indolin-2-one
QTW8MQ534B
SR-01000076222
NSC-86429
BiomolKI_000054
BiomolKI2_000060
UNII-QTW8MQ534B
UPCMLD-DP118
cis-SU 4312
Lopac0_001121
BMK1-F6
BSPBio_000998
orb1301594
orb1304047
SCHEMBL1982207
SCHEMBL29363540
UPCMLD-DP118:001
UPCMLD-DP118:002
BDBM17747
HMS1362B19
HMS1792B19
HMS1990B19
HMS3263B03
HMS3403B19
HMS3412D03
HMS3676D03
Tox21_501121
EBC-55058
NSC845011
STK946565
AKOS005640946
CCG-100658
HY-100349A
LP01121
Look up (3Z)-3-[[4-(dimethylamino)phenyl]methylidene]-1H-indol-2-one in the interactive SynDRA portal →